Novartis AG ADR

Yahoo Finance • yesterday

PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem

The VanEck Pharmaceutical ETF(NASDAQ:PPH) provides targeted exposure to drug manufacturers, while the iShares Global Healthcare ETF(NYSEMKT:IXJ) offers a broader reach across the international medical industry including biotechnology and e... Full story

Yahoo Finance • 2 days ago

Zifo, Pistoia Alliance, and Pharma Majors Launch Global IVP Assay Repository

Repository standardizes how biological assays are captured, shared, and reused Zifo worked collaboratively with regulatory authorities and Pistoia Alliance members Steering committee included representatives from AbbVie, Novartis, Merck an... Full story

Yahoo Finance • 7 days ago

ISG Event to Explore How Enterprises Are Delivering Strategic Value From AI

DraftKings, State Street, Pfizer, New York Life, Novartis, CVS Health, Bank of America, National Grid and SharkNinja will join ISG AI Impact Summit in Boston STAMFORD, Conn., May 21, 2026--(BUSINESS WIRE)--Information Services Group (ISG)... Full story

Yahoo Finance • 7 days ago

Late-Stage Chronic Kidney Disease Market Analysis Report 2026-2036, Profiles of Key Players - Novartis, Merck & Co, Pfizer, Sanofi, and Johnson & Johnson

Company Logo The late-stage chronic kidney disease (CKD) market is experiencing significant growth, driven by rising global prevalence of diabetes, hypertension, and aging populations. Advanced treatments like dialysis and kidney transpla... Full story

Yahoo Finance • 7 days ago

Polycystic Kidney Disease Market Analysis Report 2026-2036, Profiles of Key Players - Otsuka Pharmaceutical, Novartis, Pfizer, and Vertex Pharmaceuticals

Company Logo The global polycystic kidney disease (PKD) market is expanding rapidly due to rising prevalence, advanced treatments, and increased awareness. The growing cases of chronic kidney diseases (CKD) including PKD, driven by factor... Full story

Yahoo Finance • 7 days ago

Hepatic Impairment Market Analysis Report 2026-2036 Featuring AbbVie, Astellas Pharma, Gilead Sciences, F. Hoffmann La Roche, and Takeda Pharmaceuticals

Company Logo The hepatic impairment market is an essential segment within healthcare, focusing on managing liver conditions like hepatitis, NAFLD, and cirrhosis that impair liver function. The market is set for significant growth, driven... Full story

Yahoo Finance • 7 days ago

Laryngeal Cancer Market Research Report 2026-2036, Competitive Analysis of Major Players - Merck & Co., Pfizer, Novartis, and AbbVie

Company Logo The laryngeal cancer market is expanding due to advancements in treatment, early detection awareness, and diagnostic innovations, driven by rising cancer rates, especially in North America and Asia-Pacific. Lifestyle factors,... Full story

Yahoo Finance • 7 days ago

Charcot-Marie-Tooth Disease Market Growth to Accelerate Significantly During the Forecast Period (2026-2036) Driven by the Launch of Emerging Disease-Modifying Therapies | DelveInsight

The Charcot–Marie–Tooth disease market is poised for steady growth, driven by increasing disease awareness and improved diagnostic capabilities. Advancements in genetic testing are enabling earlier and more accurate diagnosis, expanding th... Full story

Yahoo Finance • 8 days ago

Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA

Novartis Pharma AG Pluvicto®PSMAddition oral presentation to highlight efficacy outcomes by disease volume and de novo/recurrent metastatic hormone-sensitive prostate cancer Kisqali® NATALEE oral presentation to report prognostic and pre... Full story

Yahoo Finance • 8 days ago

BioArctic AB (BRCTF) Q1 2026 Earnings Call Highlights: Strong Sales and Strategic Partnerships ...

This article first appeared on GuruFocus. Release Date: May 20, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points BioArctic AB (BRCTF) reported strong financial re... Full story

Yahoo Finance • 9 days ago

Novartis (SWX:NOVN) Valuation Check After New Pluvicto PSMAddition Study Data And Regulatory Filings

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Novartis (SWX:NOVN) just put fresh Pluvicto data from the Phase III PSMAddition study in front of urologists, showing stronger pro... Full story

Yahoo Finance • 9 days ago

Julia B. Fee Sotheby's International Realty Names Katie Brunner Brokerage Manager of Bedford, N.Y., Office

Seasoned real estate expert brings leadership and luxury market expertise to new role BEDFORD, N.Y., May 19, 2026 /PRNewswire/ -- Julia B. Fee Sotheby's International Realty today announced the appointment of Katie Brunner as Sales & Oper... Full story

Yahoo Finance • 9 days ago

Update: Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case

(Updates with Novo Nordisk's response in the fourth and fifth paragraphs.) The US Supreme Court o PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n... Full story

Yahoo Finance • 10 days ago

3 International ETFs for Investors Looking Beyond U.S. Stocks

Key Points Out of three popular international ETFs, the Vanguard International High Dividend Yield ETF has delivered the strongest recent ROI, with 21% average annual returns for the past three years. Buying international stocks can help... Full story

Yahoo Finance • 10 days ago

Myasthenia Gravis Market Set to Surpass USD 16 Billion by 2036, Fueled by Rising Diagnosed Prevalence and Wave of Targeted Biologic Approvals | DelveInsight

DelveInsight Business Research LLP The myasthenia gravis market size reached approximately USD 6 billion in 2025 across the 7MM and is growing at a robust CAGR of 9.1% during the forecast period. This remarkable growth is being underpinne... Full story

Yahoo Finance • 10 days ago

European Stocks Trend Higher in Monday Trading Despite Specter of Middle East War Reigniting

The European stock markets were tracking higher in Monday trading as oil prices and interest rates t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 10 days ago

Top Midday Stories: NextEra, Dominion to Combine in All-Stock Deal; Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case

The Dow Jones Industrial Average, Nasdaq Composite and S&P 500 Index were down in late-morning tradi PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 10 days ago

Hepatic Cirrhosis Market Research and Forecast Report 2026-2036, Profiles of Abbott, Astellas Pharma, Gilead Sciences, Novartis, Takeda Pharma, Grifols Therapeutics, and Cellaion

Company Logo The global hepatic cirrhosis market is expanding rapidly, fueled by increasing liver disease cases, advanced treatment options, and improved healthcare infrastructure. Conditions like hepatitis, alcohol abuse, and metabolic d... Full story

Yahoo Finance • 11 days ago

New PSMAddition data show 58% lower risk of PSA progression with Pluvicto® in metastatic hormone-sensitive prostate cancer

Novartis Pharma AG More durable, deeper PSA response in patients treated with Pluvicto plus standard of care (ARPI + ADT) vs. SoC alone Deep PSA reduction higher in patients receiving Pluvicto combination vs. SoC at 12, 24 and 48 weeks... Full story

Yahoo Finance • 13 days ago

COSENTYX Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Company Logo COSENTYX offers growth opportunities due to a large patient base fueling recurring revenue, robust global demand, double-digit growth, and an expanding label across multiple inflammatory conditions. Innovations and lifecycle... Full story